Human primordial germ cells (PGCs) have proven to be a source of pluripotent stem cells called embryonic germ cells (EGCs). Unlike embryonic stem cells, virtually little is known regarding the factors that regulate EGC survival and maintenance. In mice, the growth factor bone morphogenetic protein 4 (BMP4) has been shown to be required for maintaining mouse embryonic stem cells, and disruptions in this gene lead to defects in mouse PGC specification. Here, we sought to determine whether recombinant human BMP4 could influence EGC derivation and/or human PGC survival. We found that the addition of recombinant BMP4 increased the number of human PGCs after 1 week of culture in a dose-responsive manner. The efficiency of EGC derivation and maintenance in culture was also enhanced by the presence of recombinant BMP4 based on alkaline phosphatase and OCT4 staining. In addition, an antagonist of the BMP4 pathway, Noggin, decreased PGC proliferation and led to an increase in cystic embryoid body formation. Quantitative real-time (qRT)–polymerase chain reaction analyses and immunostaining confirmed that the constituents of the BMP4 pathway were upregulated in EGCs versus PGCs. Downstream activators of the BMP4 pathway such as ID1 and phosphorylated SMADs 1 and 5 were also expressed, suggesting a role of this growth factor in EGC pluripotency.
Get full access to this article
View all access options for this article.
References
1.
DonovanPJ, GearhartJ. 2001. The end of the beginning for pluripotent stem cells. Nature, 414:92–97.
2.
SmithAG. 2001. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol, 17:435–462.
3.
EvansMJ, KaufmanMH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature, 292:154–156.
4.
MartinGR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in media conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA, 78:7634–7638.
5.
ThomsonJA. 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
6.
AmitM, Itskovitz-EldorJ. 2006. Derivation and maintenance of human embryonic stem cells. Methods Mol Biol, 331:43–53.
7.
TurnpennyL, SpallutoCM, PerrettRMet al.2005. Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells. Stem Cells, 24:212–220.
8.
ShamblottMJ, AxelmanJ, WangSet al.1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA, 95:13726–13731.
9.
ParkJH, KimSJ, LeeJBet al.2004. Establishment of a human embryonic germ cell line and comparison with mouse and human embryonic stem cells. Mol Cells, 17:309–315.
10.
TurnpennyL, BrickwoodS, SpallutoCMet al.2003. Derivation of human embryonic germ cells: an alternative source of pluripotent stem cells. Stem Cells, 21:598–609.
11.
LiuS, LiuH, PanYet al.2004. Human embryonic germ cells isolation from early stages of post-implantation embryos. Cell Tissue Res, 318:525–531.
12.
HuaJ, YuH, LiuSet al.2009. Derivation and characterization of human embryonic germ cells: serum-free culture and differentiation potential. Reprod Biomed Online, 19:238–249.
13.
GuanK, NayerniaK, MaierLSet al.2006. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature, 440:1199–1203.
14.
IzadyarF, PauF, MarhJet al.2008. Generation of multipotent cell lines from a distinct population of male germ line stem cells. Reproduction, 135:771–784.
15.
Kanatsu-ShinoharaM, InoueK, LeeJet al.2004. Generation of pluripotent stem cells from neonatal mouse testis. Cell, 119:1001–1012.
16.
ConradS, RenningerM, HennenlotterJet al.2008. Generation of pluripotent stem cells from adult human testis. Nature, 456:344–349.
17.
KossackN, MenesesJ, ShefiSet al.2009. Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells. Stem Cells, 27:138–149.
18.
KoK, TapiaN, WuGet al.2009. Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell, 5:87–96.
PesceM, De FeliciM. 1995. Purification of mouse primordial germ cells by MiniMACS magnetic separation system. Dev Biol, 170:722–725.
21.
MatsuiY, ZseboK, HoganBL. 1992. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell, 70:841–847.
22.
ResnickJL, BixlerLS, ChengL, DonovanPJ. 1992. Long-term proliferation of mouse primordial germ cells in culture. Nature, 359:550–551.
23.
TamPP, ZhouSX. 1996. The allocation of epiblast cells to ectodermal and germ-line lineages is influenced by the position of the cells in the gastrulating mouse embryo. Dev Biol, 178:124–132.
24.
FujiwaraT, DunnNR, HoganBL. 2001. Bone morphogenetic protein 4 in the extraembryonic mesoderm is required for allantois development and the localization and survival of primordial germ cells in the mouse. Proc Natl Acad Sci USA, 98:13739–13744.
25.
LawsonKA, DunnNR, RoelenBAet al.1999. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev, 13:424–436.
26.
YingY, QiX, ZhaoGQ. 2001. Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc Natl Acad Sci USA, 98:7858–7862.
27.
YingY, LiuXM, MarbleA, LawsonKA, ZhaoGQ. 2000. Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol, 14:1053–1063.
28.
KerrCL, HillCM, BlumenthalPD, GearhartJD. 2008. Expression of pluripotent stem cell markers in the human fetal testis. Stem Cells, 26:412–421.
29.
XuC, InokumaMS, DenhamJet al.2001. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol, 19:971–974.
30.
XuRH, ChenX, LiDSet al.2002. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol, 20:1261–1264.
31.
KurosawaH. 2007. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng, 103:389–398.
32.
DudleyBM, RunyanC, TakeuchiY, SchaibleK, MolyneauxK. 2007. BMP signaling regulates PGC numbers and motility in organ culture. Mech Dev, 124:68–77.
33.
ZwakaTP, ThomsonJA. 2005. A germ cell origin of embryonic stem cells?Development, 132:227–233.
34.
KeeK, GonsalvesJM, ClarkAT, PeraRA. 2006. Bone morphogenetic proteins induce germ cell differentiation from human embryonic stem cells. Stem Cells Dev, 15:831–837.
35.
WestFD, Roche-RiosMI, AbrahamSet al.2010. KIT ligand and bone morphogenetic protein signaling enhances human embryonic stem cell to germ-like cell differentiation. Hum Reprod, 25:168–178.
36.
WatabeT, MiyazonoK. 2009. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res, 19:103–115.
37.
QiX, LiTG, HaoJet al.2004. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA, 101:6027–6032.
38.
DonovanPJ, de MiguelMP. 2003. Turning germ cells into stem cells. Curr Opin Genet Dev, 13:463–471.
39.
KerrCL, HillCM, BlumenthalPD, GearhartJD. 2008. Expression of pluripotent stem cell markers in the human fetal ovary. Hum Reprod, 23:589–599.
ShiY, MassagueJ. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113:685–700.
42.
MurakamiG, WatabeT, TakaokaK, MiyazonoK, ImamuraT. 2003. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell, 14:2809–2817.
43.
YingY, ZhaoGQ. 2001. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev Biol, 232:484–492.
44.
YingQL, NicholsJ, ChambersI, SmithA. 2003. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell, 115:281–292.
45.
ChambersI, SmithA. 2004. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene, 23:7150–7160.
46.
SuzukiA, RayaA, KawakamiYet al.2006. Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat Clin Pract Cardiovasc Med, 3,Suppl 1:S114–122.
ValdimarsdottirG, GoumansMJ, RosendahlAet al.2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation, 106:2263–2270.
49.
DasP, EzashiT, SchulzLC, WestfallSD, LivingstonKA, RobertsRM. 2007. Effects of fgf2 and oxygen in the bmp4-driven differentiation of trophoblast from human embryonic stem cells. Stem Cell Res, 1:61–74.
50.
De FeliciM, FariniD, DolciS. 2009. In or out stemness: comparing growth factor signalling in mouse embryonic stem cells and primordial germ cells. Curr Stem Cell Res Ther, 4:87–97.
51.
MolyneauxK, WylieC. 2004. Primordial germ cell migration. Int J Dev Biol, 48:537–544.
52.
PesceM, Gioia KlingerF, De FeliciM. 2002. Derivation in culture of primordial germ cells from cells of the mouse epiblast: phenotypic induction and growth control by Bmp4 signalling. Mech Dev, 112:15–24.
53.
PesceM, WangX, WolgemuthDJ, ScholerH. 1998. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev, 71:89–98.
54.
HuangY, GuB, WuR, ZhangJ, LiY, ZhangM. 2007. Development of a rabbit monoclonal antibody group against Smads and immunocytochemical study of human and mouse embryonic stem cells. Hybridoma, 26:387–391.
55.
KodairaK, ImadaM, GotoMet al.2006. Purification and identification of a BMP-like factor from bovine serum. Biochem Biophys Res Commun, 345:1224–1231.
56.
XuRH, Sampsell-BarronTL, GuFet al.2008. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell, 3:196–206.
57.
VallierL, AlexanderM, PedersenRA. 2005. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci, 118,Pt 19:4495–4509.
RuzinovaMB, BenezraR. 2003. Id proteins in development, cell cycle and cancer. Trends Cell Biol, 13:410–418.
60.
StahlbergA, BengtssonM, HembergM, SembH. 2009. Quantitative transcription factor analysis of undifferentiated single human embryonic stem cells. Clin Chem, 55:2162–2170.
61.
YamaguchiS, KurimotoK, YabutaYet al.2009. Conditional knockdown of Nanog induces apoptotic cell death in mouse migrating primordial germ cells. Development, 136:4011–4020.
62.
ChambersI, ColbyD, RobertsonMet al.2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 113:643–655.
63.
MitsuiK, TokuzawaY, ItohHet al.2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 113:631–642.
64.
HatanoSY, TadaM, KimuraHet al.2005. Pluripotential competence of cells associated with Nanog activity. Mech Dev, 122:67–79.
65.
HartAH, HartleyL, IbrahimM, RobbL. 2004. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn, 230:187–198.
SasagawaM, WatanabeS, OhmomoY, HonmaS, KanazawaK, TakeuchiS. 1986. Reactivity of two monoclonal antibodies (Troma 1 and CAM 5.2) on human tissue sections: analysis of their usefulness as a histological trophoblast marker in normal pregnancy and trophoblastic disease. Int J Gynecol Pathol, 5:345–356.
CrossJC. 2000. Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol, 11:105–113.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
